학술논문
RELAY, Ramucirumab Plus Erlotinib (RAM+ERL) in Untreated Metastatic EGFR-Mutant NSCLC (EGFR+ NSCLC): Association Between TP53 Status and Clinical Outcome
Document Type
Article
Author
Source
In Clinical Lung Cancer July 2023 24(5):415-428
Subject
Language
ISSN
1525-7304